Smart Nebulizer

Smart Nebulizer

A smart nebulizer is a medical device that uses technology to deliver medication to patients in the form of a fine mist. Unlike traditional nebulizers, which require the patient to inhale the medication through a face mask, a smart nebulizer can be used with a mouthpiece or nose clip. The global demand for smart nebulizers is increasing due to the expanding predominance of respiratory disorders and the requirement for successful and advantageous therapy choices. As indicated by the World Health Organization (WHO), respiratory infections are a main source of death around the world, with an expected 3 million passings each year.

Smart Nebulizer Market is expected to grow at a strong CAGR of 12.5% during the forecast period owing to growing awareness of the importance of oral health and the development of new and advanced devices. For instance, in January 2022, Wellinks, the manufacturer of the nebulizer, a review board of the U.S. Food and Drug Administration (FDA) approved the first wireless nebulizer for use by people with chronic obstructive pulmonary disease (COPD). Further, the technological advancements and rising involvement of major players in medical technologies are also attributing factors to the market growth of smart nebulizers.

• Based on type, the market is segmented into portable smart nebulizers, handheld smart nebulizers, and table-top smart nebulizers. The portable smart nebulizers segment held a dominant share of the market in 2021 mainly due to reducing the number of visits to the hospital and the emergency room, smart nebulizers' portability can help cut healthcare costs. This is especially significant for patients with constant respiratory circumstances, who might require incessant dosages of medicine over the course of the day.
• On the basis of application, the market is segmented into chronic obstructive pulmonary disease (COPD), cystic fibrosis, asthma, and others. The chronic obstructive pulmonary disease (COPD) segment is expected to witness major growth during the forecast period. Smart nebulizers are an efficient COPD treatment option because they are made to deliver medication directly to the lungs. Nearly 90% of COPD deaths in those under 70 years of age occur in low- and middle-income countries, as per the World Health Organization, in 2023. They are an appealing option for patients who may have mobility issues because they are more portable and simpler to use than traditional nebulizers.
• On the basis of end-user, the market is segmented into hospitals & clinics, emergency centers, and home healthcare. The hospitals & clinics held the dominant share of the market in 2021. Hospitals and clinics play a critical role in ensuring that patients have access to these treatments and that they are used safely and effectively due to favorable reimbursement policies and the increased number of patients. Emergency clinics are a necessary part of the medical services industry and are a significant income hotspot for the whole business. As per the National Center for environmental health, in 2022, around 5.2 crude rates per 10,000 population are Hospital Inpatient Stays due to asthma in 2019.
• For a better understanding of the market adoption of the industry, the market is analyzed based on its worldwide presence in the countries such as North America (U.S., Canada, and the Rest of North America), Europe (Germany, UK, France, Italy, Spain, Rest of Europe), Asia-Pacific (China, Japan, India, South Korea, Australia, and Rest of Asia-Pacific), Rest of World. North America dominated the market of smart nebulizer market. The growing demand for smart nebulizers can be attributed due to the surge in the prevalence of respiratory disorders and the continuously rising geriatric population in the region. Further, the increased consumption of alcohol and smoking are other important factors responsible for the market growth of smart nebulizers in the North American region. As per the Centers for Disease Control and Prevention, in 2023, an expected 28.3 million U.S. grown-ups smoke cigarettes, and around 3.08 million U.S. center and secondary school understudies use no less than one tobacco item, including e-cigarettes. About 1,600 young people under the age of 18 in the United States smoke their first cigarette each day.
• Some of the major players operating in the market include OMRON Corporation, Briggs Healthcare, Vectura Group Ltd, PARI GmbH, Koninklijke Philips N.V., Briutcare, GE HealthCare, AireHealth, Beurer GmbH, BPL Medical Technologies.